A Research Study to Explore the Impact of GP Support Via Text Messages to Patients With Asthma and/or COPD - Trial NCT06419400
Access comprehensive clinical trial information for NCT06419400 through Pure Global AI's free database. This phase not specified trial is sponsored by Accurx and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 6053 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Accurx
Timeline & Enrollment
N/A
Apr 01, 2022
Nov 01, 2023
Primary Outcome
Improved self-reported medication taking as measured by the The Medication Adherence Report Scale (MARS-5) Questionnaire
Summary
A 6-month randomised controlled trial to evaluate the impact of text message support on
 symptom control and inhaler adherence for patients with asthma and/or COPD
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06419400
Non-Device Trial